Latest Breaking News On - Lingshi - Page 8 : vimarsana.com

Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics News provided by Share this article Share this article HANGZHOU, China and SHANGHAI, March 2, 2021 /PRNewswire/  Innoforce, a biopharmaceutical innovation enabling platform and PDMO (Partner Development and Manufacturing Organization), and dMed, a clinical CRO with strong presence in China and the US - the world s two largest pharmaceutical and drug development markets, have signed an agreement under which the two parties agreed to establish a partnership to identify, assess, and collaborate on the development of clinical-stage therapeutics. Dr. Lingshi Tan, founder and CEO of dMed said, Our partnership with Innoforce will provide a powerful avenue to help clinical-stage therapeutic development programs from small and medium companies and to accelerate the pace of clinical development.

Yuling liGoliang yuPartner developmentInnforce cgtx servicesThermo fisherClinical contract research organizationManufacturing organizationThermo fisher biopharma services hangzhouLingshi tanThermo fisher biopharma servicesHangzhou airport economic zoneHangzhou bay biotech valleyPharma intelligenceகூட்டாளர் வளர்ச்சிதெர்மோ மீனவர்மருத்துவ ஒப்பந்த ஆராய்ச்சி ஆர்கநைஸேஶந்